Skip to main navigation

Top bar

Biogen.com Information Request Sign up for Alerts Search

Investor Relations

Overview

News

Events Presentations

SEC Filings Annual Reports

Stock Quote & Chart Analyst Coverage Investor FAQs

Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board

News

News

News Category

Year

June 9, 2009

Biogen Idec to Present at the Goldman Sachs 30th Annual Healthcare Conference

June 4, 2009

Biogen Idec Announces Preliminary Results of Stockholder Vote

May 31, 2009

Subset Data from Two Randomized Phase 3 Trials Show TYSABRI® Significantly Improves Health-Related Quality of Life for Crohn’s Disease Patients with Prior Exposure or Inadequate Response to Anti-TNFα Therapy

May 27, 2009

Biogen Idec Joins with the Global MS Community to Mark World MS Day

May 26, 2009

Biogen Idec Sends Letter to Stockholders

May 24, 2009

Biogen Idec Comments on Proxy Advisory Firms’ Reports

May 19, 2009

Genentech and Biogen Idec Submit Applications to the FDA for Rituxan for Most Common Type of Adult Leukemia

May 14, 2009

Biogen Idec to Present at the Deutsche Bank 34th Annual Health Care Conference

April 30, 2009

First Ten-Year Follow-Up Shows That Treatment with AVONEX® Leads to Long-Term Benefits in Early Multiple Sclerosis Patients

April 28, 2009

MRI Data Showing TYSABRI® Promoted Remyelination Presented at the 61st Annual Meeting of the American Academy of Neurology

Pagination

First page
Previous page
…
Page 65
Page 66
Page 67
Page 68
Current page 69
Page 70
Page 71
Page 72
Page 73
…
Next page
Last page

Displaying 681 - 690 of 763

Footer

Investors
Careers
Our Stories
Contact Us

Follow us

Bottom

Privacy Policy
Terms & Conditions
Forward-Looking Statements
Community Guidelines

Investor Relations

Overview

News

Events & Presentations

Events
Presentations

Financials

SEC Filings
Annual Reports

Stock Information

Stock Quote & Chart
Analyst Coverage
Investor FAQs

Corporate Governance

Governance Documents
Committee Composition & Charters
Leadership
Code of Business Conduct
Contact the Board

Top bar

Biogen.com

Information Request

Sign up for Alerts

Search

Follow us